ERFIP2013

2013 Epilepsy Research Forum

 Coordinatore CHANCEL LIMITED 

 Organization address address: PRIORY HALL 7
city: STILLORGAN
postcode: CO

contact info
Titolo: Mr.
Nome: Eoin
Cognome: Sheanon
Email: send email
Telefono: 35312056720

 Nazionalità Coordinatore Ireland [IE]
 Totale costo 255˙501 €
 EC contributo 100˙000 €
 Programma FP7-HEALTH
Specific Programme "Cooperation": Health
 Code Call FP7-HEALTH-2012-INNOVATION-1
 Funding Scheme CSA-SA
 Anno di inizio 2012
 Periodo (anno-mese-giorno) 2012-07-01   -   2013-12-31

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    CHANCEL LIMITED

 Organization address address: PRIORY HALL 7
city: STILLORGAN
postcode: CO

contact info
Titolo: Mr.
Nome: Eoin
Cognome: Sheanon
Email: send email
Telefono: 35312056720

IE (STILLORGAN) coordinator 100˙000.00
2    INTERNATIONAL BUREAU FOR EPILEPSY INC NON PROFIT CORPORATION

 Organization address address: 15TH STREET 1015 NW SUITE 1000
city: WASHINGTON DC
postcode: 20005

contact info
Titolo: Ms.
Nome: Ann
Cognome: Little
Email: send email
Telefono: 35312108850

US (WASHINGTON DC) participant 0.00
3    INTERNATIONAL LEAGUE AGAINST EPILEPSY

 Organization address address: NORTH MAIN STREET 342
city: WEST HARTFORD CT
postcode: 06117 2507

contact info
Titolo: Prof.
Nome: Emilio
Cognome: Perucca
Email: send email
Telefono: 39038222741

US (WEST HARTFORD CT) participant 0.00

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

conference    forum    stigma    made    seizures    coordinated    disorder    national    characterised    union    brain    stakeholders    people    seek    patients    epilepsy   

 Obiettivo del progetto (Objective)

'Epilepsy is a brain disorder that is characterised by recurrent episodes of cerebral dysfunction, that is, seizures which are caused by excessive electrical discharges of nerve cells. It is one of the most common serious disorders of the brain. Six million people in Europe have Epilepsy and approximately 300,000 new cases are diagnosed each year. The Epilepsy Research Forum 2013 will seek to contribute to the debate on the coordination of research at national and European Union level as well and to focus on research achievements made to date and the opportunities for further advances. By bringing together a wide spectrum of stakeholders it is hoped that national and European epilepsy research networks will be better coordinated and targeted. With an expected attendance of 500 stakeholders, the Conference will stimulate debate on, in the first instance, promoting research into improving the diagnosis and treatment of epilepsy. The Conference programme will also aim at improving awareness and reducing stigma, in what will essentially be a multifaceted conference engaging clinicians and patients alike.

The specific objectives are:

-to promote and discuss the opportunities for coordinated, targeted and precise innovative research efforts that would build on the significant gains made by basic and clinical research in the past

-the 2013 Forum, whilst aimed primarily at facilitating research opportunities in epilepsy, will also seek to address the optimal standards of care for people with epilepsy which are still unequally distributed in European Union'

Introduzione (Teaser)

Epilepsy is a neurological disorder characterised by seizures and that affects millions of people globally. Epileptic patients have poor quality of life and suffer from social stigma.

Altri progetti dello stesso programma (FP7-HEALTH)

BIOMARGIN (2013)

Biomarkers of renal graft injuries in kidney allograft recipients

Read More  

COMBIMS (2013)

A novel drug discovery method based on systems biology: combination therapy and biomarkers for Multiple Sclerosis

Read More  

I.D.A.C. (2012)

Implant Disposable Antibacterial Coating (I.D.A.C.): a Novel Approach to Implant-Related Infections in Orthopaedics and Trauma Surgery

Read More